AscendRx Announces Rebrand to QuicksortRx

CHARLESTON, S.C., March 4, 2020 /PRNewswire/ — AscendRx, Inc., a software company spun out of the Medical University of South Carolina, has announced that it will operate under a new name and will be known as QuicksortRx Inc. This rebranding represents the company as it helps pharmacy supply chain teams make faster and more informed decisions for their health systems. The company’s ownership and staff have not changed.

CEO Jonathan Yantis stated “It is important that our brand represents our company’s vision to empower pharmacy leadership and staff with better technology, and to elevate what matters most in their daily supply chain work. We are excited to move forward with our new name, QuicksortRx, as we continue to serve health systems and decrease the cost of healthcare.”

QuicksortRx Inc was founded by pharmacists and technologists at the Medical University of South Carolina who understand the potential in health system supply chain and develop key solutions to unlocking it. QuicksortRx software identifies medication savings in real time, streamlining execution without increasing staff workload.

To learn more about QuicksortRx, visit quicksortrx.com, or contact team@quicksortrx.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/ascendrx-announces-rebrand-to-quicksortrx-301015807.html

SOURCE QuicksortRx

Staff

Recent Posts

RESPIREE SECURES SINGAPORE HSA APPROVAL FOR ITS AI-ENABLED 1BIO™AI SOFTWARE TO SUPPORT ACUTE DETERIORATION DETECTION

SINGAPORE, Dec. 7, 2025 /PRNewswire/ -- AI/ML health-tech startup Respiree has received approval from the Health…

38 minutes ago

AI-for-Science Startup ChemLex Raises USD 45M, Launching Self-Driving Lab for Drug Discovery in Singapore

SINGAPORE, Dec. 7, 2025 /PRNewswire/ -- ChemLex, a next-generation AI-for-science company, today announced the establishment…

39 minutes ago

Is The DEA in Systemic Collapse: Corruption, Constitutional Violations, and a Seven-Year War Against Marijuana Medical Science

The DEA was created to combat cartel trafficking, protect public health, and ensure researchers have…

16 hours ago

Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease

CAMBRIDGE, Mass., Dec. 07, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology…

16 hours ago

Secura Bio Presents Extended Follow Up Analyses from Phase 2 PRIMO Trial in Patients with Relapsed/Refractory peripheral T-cell lymphoma at the 2025 American Society of Hematology Meeting

Longer-term analyses reinforce duvelisib’s activity across treatment-experienced PTCL populations, including patients with ≥3 prior lines…

16 hours ago